Loading clinical trials...

Active Not RecruitingPhase 2NCT04198727

Study of the Impact of DPD Activity on the Efficacy of Capecitabine

This study evaluates the Impact of DihydroPyrimidine Dehydrogenase (DPD) activity on the efficacy of Capecitabine in patients with metastatic breast cancer. The DPD phenotype before the initiation of ...

Lead sponsor: Centre Antoine Lacassagne•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy

NCT05941299 · Mastectomy, Segmental, Breast Neoplasm Malignant Female

RECRUITINGNA

SBRT for Breast Cancer Oligometastases

NCT04424732 · Breast Neoplasm Malignant Female

COMPLETEDPhase 1

Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

NCT03109080 · Breast Neoplasms, Triple-Negative, Breast Neoplasm Malignant Female, and more

TERMINATEDPhase 4

Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)

NCT04289805 · Breast Neoplasm Malignant Female

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 23, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE2

Enrollment155

Start dateJul 2020

Last updatedMay 23, 2025

Condition

Breast Neoplasm Malignant Female

Locations shown

Clinique Saint Jean

Cagnes-sur-Mer

Centre Azuréen de Cancérologie

Mougins

Clinique St Georges

Nice

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions